Respiratory syncytial virus bronchiolitis – Basic Information

Go back

Respiratory syncytial virus bronchiolitis is a lung infection affecting the tiniest airways in young children, most commonly caused by RSV. While many babies experience only mild cold-like symptoms, some develop serious breathing difficulties requiring hospital care, especially those under six months old.

Understanding the Disease and Who It Affects

Respiratory syncytial virus bronchiolitis occurs when a viral infection causes inflammation and swelling in the bronchioles, which are the smallest air passages deep inside the lungs. When these tiny tubes become inflamed and filled with mucus, air cannot flow freely, making it hard for a child to breathe properly. The most common virus responsible for this condition is respiratory syncytial virus, or RSV, though other viruses can also trigger bronchiolitis.[1][2]

This condition primarily strikes infants and young children under two years of age. The reason young babies are so vulnerable is that their airways are naturally very small, so even a small amount of swelling can block airflow significantly. Additionally, their immune systems are still developing and haven’t yet learned how to fight off this particular virus effectively.[2][3]

How Common Is This Infection?

Bronchiolitis caused by RSV is remarkably widespread among young children. Nearly all children become infected with RSV at least once before their second birthday, and about half of these children will contract it twice during their first two years of life. During the first year of life alone, the incidence of bronchiolitis ranges from 11% to 15% of all infants.[1][4]

While most children recover at home without complications, a significant number require medical attention. In the United States, approximately 2% to 3% of infants younger than 12 months are hospitalized with RSV infection each year. This translates to more than 57,500 hospitalizations and 2.1 million outpatient visits associated with RSV infections annually in U.S. children younger than five years. The condition accounts for at least five hospitalizations for every 1,000 children younger than two years of age.[2][4]

The illness follows a predictable seasonal pattern. In the United States, RSV infections occur most commonly between October and May, with cases peaking in December through March. During these winter months, emergency departments and pediatric hospitals experience surges in young patients struggling to breathe due to bronchiolitis.[2][3]

⚠️ Important
The strongest predictor of hospitalization is a child’s age, with the highest risk occurring in the first 90 days of life. Babies younger than three months are especially vulnerable to severe illness and require close monitoring if they develop any breathing problems.

How the Virus Spreads

RSV spreads remarkably easily from person to person, which explains why nearly every child eventually catches it. The virus travels through respiratory droplets that an infected person releases when coughing or sneezing. A child can become infected by having direct contact with someone who is sick, or by touching surfaces contaminated with the virus and then touching their own eyes, mouth, or nose.[2][3]

The virus is remarkably hardy and can survive on hard surfaces like toys, countertops, and furniture for several hours. This durability makes places where many children gather—such as daycare centers, nurseries, and doctor’s waiting rooms—particularly high-risk environments for transmission. An infected person can spread the virus for three to eight days while they have symptoms, and sometimes they can pass it along even a day or two before symptoms appear.[3][6]

Who Is at Highest Risk?

While any infant can develop bronchiolitis, certain groups face a much higher risk of severe illness requiring hospitalization. Infants younger than three months are particularly vulnerable, especially those born prematurely (before 32 to 34 weeks of pregnancy). Premature babies have smaller, less developed airways and immature immune systems, making them less able to handle respiratory infections.[4][2]

Children with underlying medical conditions face elevated risks as well. These high-risk groups include those with chronic lung disease (such as bronchopulmonary dysplasia, a condition affecting premature infants), congenital heart disease, neuromuscular disorders, or weakened immune systems. Children with cystic fibrosis or those undergoing chemotherapy are also more susceptible to severe complications.[4][6]

Additional risk factors that increase the likelihood of severe infection include low birth weight, exposure to tobacco smoke (especially if parents smoke), living in crowded conditions, and coming from lower socioeconomic populations. Male infants also appear to be at slightly higher risk than females.[4]

Recognizing the Symptoms

The illness typically begins like an ordinary cold. Parents usually notice two to four days of upper respiratory symptoms that seem unremarkable: a runny or stuffy nose, mild fever, congestion, and perhaps some sneezing. During this early phase, many parents don’t realize their child has anything more serious than a common cold. Symptoms typically appear about four to six days after exposure to the virus.[1][2]

However, after these initial cold-like symptoms, the infection can progress to affect the lower airways. This is when bronchiolitis becomes apparent. The child develops an increasing cough, and parents begin to hear wheezing—a high-pitched whistling or purring sound that occurs when the child breathes out. The child’s breathing becomes noticeably faster than normal, often exceeding 40 breaths per minute, and they may appear to be working hard to push air out of their lungs.[2][4]

In very young infants, especially those under six months, the symptoms may look different. These tiny babies might become unusually irritable or lethargic, refuse to eat or drink, or experience frightening pauses in breathing called apnea. Some infants don’t develop a fever at all, which can make parents underestimate the severity of the illness.[1]

Warning signs that indicate a child needs immediate medical attention include struggling with each breath, chest muscles and skin pulling inward with each breath (called retractions), nostrils flaring out when breathing, rapid or shallow breathing, pauses in breathing, a bluish color appearing around the lips or face, extreme difficulty feeding, or the child becoming unusually sleepy or unresponsive.[1][6]

Preventing the Spread

Since no cure exists for viral bronchiolitis, prevention becomes extremely important. The most effective preventive measure is simple but crucial: frequent handwashing. Parents, caregivers, and anyone who comes into contact with infants should wash their hands thoroughly and often, especially after coughing, sneezing, or touching potentially contaminated surfaces.[2]

People who are sick should stay away from young infants whenever possible. If someone in the household has cold symptoms, they should cover their nose and mouth with a tissue when coughing or sneezing and avoid kissing or closely handling the baby until they recover. Toys and surfaces that young children frequently touch should be cleaned regularly, as the virus can survive on these objects for hours.[3]

For high-risk infants, medical prevention options exist. A medication called palivizumab is a monoclonal antibody that can help protect vulnerable babies. This preventive treatment is recommended for specific groups: infants born before 29 weeks of pregnancy, infants with chronic lung disease of prematurity, and infants and children with significant heart disease. The medication is given as a monthly injection during RSV season, typically from November through March, for up to five doses.[2][8]

More recently, additional preventive options have become available. A vaccine can be given to pregnant women to help protect their babies after birth, and a newer immunization option called nirsevimab can be given to infants before or during their first RSV season. These tools represent significant advances in protecting the most vulnerable babies from severe illness.[12]

What Happens Inside the Body

Understanding what bronchiolitis does inside the lungs helps explain why children become so sick. When RSV enters the respiratory tract, it infects the cells lining the airways, particularly targeting the epithelial cells in the bronchioles. The virus causes direct damage to these cells, leading to their death and destruction. This process is called necrosis.[2][4]

As infected cells die and slough off, they mix with mucus to create thick plugs that block the tiny bronchioles. The body’s immune system responds to the infection by triggering inflammation, which causes the airway walls to swell. This combination of mucus plugs, dead cells, and swelling severely narrows the air passages.[4]

The narrowed, blocked airways create a cascade of breathing problems. Air becomes trapped in parts of the lung, causing hyperinflation (over-expansion of the lungs), while other areas collapse, a condition called atelectasis. The child must work much harder to move air in and out of their lungs. Oxygen levels in the blood may drop because blocked airways prevent efficient gas exchange. Meanwhile, the effort of breathing becomes exhausting, and in severe cases, a child can develop respiratory fatigue where their breathing muscles simply cannot keep up with the demands.[4]

The inflammatory response also affects lung compliance, meaning the lungs become stiffer and harder to expand. This stiffness, combined with airway obstruction, creates the characteristic wheezing sound and rapid breathing pattern seen in bronchiolitis. The body tries to compensate by breathing faster and working harder, but this compensation can only go so far before a child needs medical support.[4]

⚠️ Important
About 30% of children who experience bronchiolitis in early childhood may later develop asthma. This risk increases if the child has close family members with asthma or if they develop bronchiolitis more than twice. The connection between early RSV infection and later respiratory problems is an active area of research.

Ongoing Clinical Trials on Respiratory syncytial virus bronchiolitis

  • Study on the Immune Response and Safety of RSVPreF3 Vaccine in Adults 18-49 at Risk for Respiratory Syncytial Virus Compared to Adults 60 and Older

    Not recruiting

    3 1 1 1
    Germany
  • Study on Preventing Respiratory Issues from RSV Bronchiolitis in Preterm Babies Using Palivizumab

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Italy

References

https://www.mayoclinic.org/diseases-conditions/respiratory-syncytial-virus/symptoms-causes/syc-20353098

https://www.aafp.org/pubs/afp/issues/2017/0115/p94.html

https://www.cdc.gov/rsv/about/index.html

https://www.ncbi.nlm.nih.gov/books/NBK441959/

https://health.ucdavis.edu/news/headlines/what-you-need-to-know-about-bronchiolitis-a-complication-of-rsv/2022/11

https://my.clevelandclinic.org/health/diseases/rsv-respiratory-syncytial-virus

https://www.nationwidechildrens.org/family-resources-education/700childrens/2015/02/rsv-and-bronchiolitis-what-do-i-need-to-know

https://www.aafp.org/pubs/afp/issues/2004/0115/p325.html

https://pmc.ncbi.nlm.nih.gov/articles/PMC3461981/

https://www.mayoclinic.org/diseases-conditions/respiratory-syncytial-virus/diagnosis-treatment/drc-20353104

https://www.aafp.org/pubs/afp/issues/2017/0115/p94.html

https://www.chop.edu/news/health-tip/how-treat-rsv-home-and-when-go-doctor

https://my.clevelandclinic.org/health/diseases/rsv-respiratory-syncytial-virus

https://www.childrensnational.org/get-care/health-library/respiratory-syncytial-virus-rsv

https://pmc.ncbi.nlm.nih.gov/articles/PMC4008286/

https://www.mayoclinic.org/diseases-conditions/bronchiolitis/diagnosis-treatment/drc-20351571

https://emedicine.medscape.com/article/971488-treatment

https://www.mayoclinic.org/diseases-conditions/respiratory-syncytial-virus/symptoms-causes/syc-20353098

https://my.clevelandclinic.org/health/diseases/rsv-respiratory-syncytial-virus

https://www.seattlechildrens.org/conditions/a-z/bronchiolitis-rsv/

https://www.cdc.gov/rsv/infants-young-children/index.html

https://www.childrenscolorado.org/conditions-and-advice/conditions-and-symptoms/conditions/bronchiolitis/

https://www.aafp.org/pubs/afp/issues/2017/0115/p94.html

https://resc-eu.org/parents-patients/rsv/faqs-about-rsv-bronchiolitis/

FAQ

How long does RSV bronchiolitis typically last?

Most children with RSV bronchiolitis improve within 7 to 10 days, though symptoms can last two weeks or more in some cases. The cough may persist for three weeks or longer even after other symptoms resolve. The first few days after cold symptoms appear are usually when breathing problems develop and worsen.

Can adults get RSV bronchiolitis?

Adults can get RSV infections, but they typically experience only mild, cold-like symptoms rather than bronchiolitis. However, adults over 65 and those with weakened immune systems, heart disease, or chronic lung conditions can develop serious complications similar to those seen in infants. RSV causes thousands of hospitalizations in elderly adults each year.

Is there a vaccine or treatment for RSV bronchiolitis?

Treatment is mainly supportive care, including supplemental oxygen, fluids, and monitoring. There is no specific antiviral cure that works for most cases. However, preventive medications exist for high-risk babies, including palivizumab (monthly injections during RSV season) and newer options like nirsevimab. A vaccine for pregnant women can also help protect newborns.

When should I take my child to the emergency room?

Seek emergency care if your child is struggling for each breath, has bluish lips or face, shows skin pulling in between the ribs with breathing, has nostrils flaring with each breath, experiences pauses in breathing, appears extremely lethargic, or refuses to drink and shows signs of dehydration. For babies under three months, any worsening of symptoms warrants immediate medical evaluation.

Do antibiotics help treat RSV bronchiolitis?

No, antibiotics do not help because RSV is a virus, not a bacteria. Antibiotics only work against bacterial infections. They should only be given if a secondary bacterial infection develops, such as bacterial pneumonia or an ear infection, which doctors can confirm or suspect based on examination and sometimes testing.

🎯 Key takeaways

  • Nearly every child will contract RSV by age two, but babies under three months face the highest risk of severe illness requiring hospitalization.
  • What starts as a simple cold can progress to serious breathing difficulties within days as the virus blocks and inflames the smallest airways in the lungs.
  • RSV season peaks from December to March, causing more than 57,500 hospitalizations and 2.1 million doctor visits annually in young U.S. children.
  • The virus spreads incredibly easily through coughs, sneezes, and contaminated surfaces, where it can survive for hours.
  • Watch for warning signs like rapid breathing, wheezing, chest retractions, bluish coloring, or feeding difficulties—these signal the need for immediate medical attention.
  • Treatment focuses on supportive care with oxygen and fluids; most medications like bronchodilators and steroids aren’t helpful for typical cases.
  • Prevention through handwashing and keeping sick people away from infants is crucial, and new immunizations can protect high-risk babies during RSV season.
  • Children who experience bronchiolitis have a 30% chance of later developing asthma, especially if they have family members with asthma or multiple episodes.